logo

For the Inventor, By the Inventor

Sandwich, United Kingdom

Philip Charles Levett

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2001-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Charles Levett. Retrieved from https://idiyas.com/inventor/philip-charles-levett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 42.9

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • County of Kent, GB (2002 - 2004)
  • Kent, GB (2004 - 2006)
  • Sandwich, GB (2001 - 2007)

Company Filing History:

goldMedal7 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 2001-2007

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7176311 - Process for preparing pharmaceutically active compounds (2007-02-13),
2. 7067660 - Process for the preparation of pyrazolopyrimidinones (2006-06-27),
3. 6809200 - Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof (2004-10-26),
4. 6730786 - Process for the preparation of pyrazolopyrimidinones (2004-05-04),
5. 6677335 - Pharmaceutically active compounds (2004-01-13),
6. 6407259 - Process for the preparation of pyrazoles (2002-06-18),
7. 6207829 - Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof (2001-03-27),

Title: The Innovations of Philip Charles Levett

Introduction

Philip Charles Levett is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work primarily focuses on developing compounds that have therapeutic applications, particularly in treating sexual dysfunction.

Latest Patents

Levett's latest patents include a process for preparing pharmaceutically active compounds. This process involves the preparation of compounds that act as potent and selective inhibitors of type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5). These compounds have shown utility in treating male erectile dysfunction (MED) and female sexual dysfunction (FSD). Another significant patent is for the preparation of pyrazolopyrimidinones, which involves the dehydrogenation of specific compounds to produce new therapeutic agents.

Career Highlights

Levett's career is marked by his association with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approaches have led to advancements in the treatment of various medical conditions.

Collaborations

Levett has collaborated with esteemed colleagues such as Mark Edward Bunnage and Laurence James Harris. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Philip Charles Levett's contributions to pharmaceutical innovations are noteworthy. His patents reflect a commitment to improving health outcomes through scientific advancements. His work continues to influence the field and pave the way for future developments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…